CheckmAb S.r.l.
PrivateLast Round
Seed
Dec 11, 2025
Est. Valuation
$12.3M
Total Funding Raised
$12.78M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
CheckmAb S.r.l. is a biotechnology company that develops monoclonal antibodies for cancer immunotherapy by targeting tumor-infiltrating regulatory T lymphocytes.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CheckmAb S.r.l. Comparables
Compare CheckmAb S.r.l. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Alderaan Biotechnology | 88% | |
| Egle Therapeutics | 77% | |
| Kainova Therapeutics | 76% |
CheckmAb S.r.l. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Dec 11, 2025 | ||||
| Series A | Mar 14, 2018 |
CheckmAb S.r.l. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Primo Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 17, 2026
Monthly visitors increased 165% MoM.
- Mar 14, 2018
$7.38M round led by Primo Capital.
CheckmAb S.r.l. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about CheckmAb S.r.l.'s valuation, stock price, and market status.
Is CheckmAb S.r.l. a public or private company?
CheckmAb S.r.l. is a private company.
What is the current stock price of CheckmAb S.r.l.?
CheckmAb S.r.l. is a private company with no public stock price. No recent secondary market data is available.
How much is CheckmAb S.r.l. worth (valuation)?
CheckmAb S.r.l.'s valuation is estimated at $12.3M based on funding round data.
Can I buy CheckmAb S.r.l. stock?
CheckmAb S.r.l. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was CheckmAb S.r.l.'s last funding round?
CheckmAb S.r.l.'s most recent funding round was Seed on March 14, 2018.
Who are the main investors in CheckmAb S.r.l.?
Key investors in CheckmAb S.r.l. include Primo Capital.
Will CheckmAb S.r.l. IPO soon?
No public IPO plans have been announced for CheckmAb S.r.l..
How can I track CheckmAb S.r.l. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor CheckmAb S.r.l.'s secondary market activity and sign up for updates.